BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28270531)

  • 1. Principles of Reconstructing the Subclonal Architecture of Cancers.
    Dentro SC; Wedge DC; Van Loo P
    Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28270531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decomposing the subclonal structure of tumors with two-way mixture models on copy number aberrations.
    Tai AS; Peng CH; Peng SC; Hsieh WP
    PLoS One; 2018; 13(12):e0206579. PubMed ID: 30540749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMPASS: joint copy number and mutation phylogeny reconstruction from amplicon single-cell sequencing data.
    Sollier E; Kuipers J; Takahashi K; Beerenwinkel N; Jahn K
    Nat Commun; 2023 Aug; 14(1):4921. PubMed ID: 37582954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.
    Goswami RS; Patel KP; Singh RR; Meric-Bernstam F; Kopetz ES; Subbiah V; Alvarez RH; Davies MA; Jabbar KJ; Roy-Chowdhuri S; Lazar AJ; Medeiros LJ; Broaddus RR; Luthra R; Routbort MJ
    Clin Cancer Res; 2015 Jun; 21(11):2644-51. PubMed ID: 25695693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
    Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
    Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
    [No Abstract]   [Full Text] [Related]  

  • 6. TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors.
    Nieboer MM; Dorssers LCJ; Straver R; Looijenga LHJ; de Ridder J
    PLoS One; 2018; 13(11):e0208002. PubMed ID: 30496231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
    Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
    PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the influence of mutation detection on tumour subclonal reconstruction.
    Liu LY; Bhandari V; Salcedo A; Espiritu SMG; Morris QD; Kislinger T; Boutros PC
    Nat Commun; 2020 Dec; 11(1):6247. PubMed ID: 33288765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 10. Inferring clonal evolution of tumors from single nucleotide somatic mutations.
    Jiao W; Vembu S; Deshwar AG; Stein L; Morris Q
    BMC Bioinformatics; 2014 Feb; 15():35. PubMed ID: 24484323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative inference of subclonal tumour evolution from single-cell and bulk sequencing data.
    Malikic S; Jahn K; Kuipers J; Sahinalp SC; Beerenwinkel N
    Nat Commun; 2019 Jun; 10(1):2750. PubMed ID: 31227714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MixClone: a mixture model for inferring tumor subclonal populations.
    Li Y; Xie X
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25707430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
    Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P;
    Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
    Yu Z; Li A; Wang M
    BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc.
    Antonello A; Bergamin R; Calonaci N; Househam J; Milite S; Williams MJ; Anselmi F; d'Onofrio A; Sundaram V; Sosinsky A; Cross WCH; Caravagna G
    Genome Biol; 2024 Jan; 25(1):38. PubMed ID: 38297376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
    Yu Z; Li A; Wang M
    BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing.
    Bonneville R; Paruchuri A; Wing MR; Krook MA; Reeser JW; Chen HZ; Dao T; Samorodnitsky E; Smith AM; Yu L; Nowacki N; Chen W; Roychowdhury S
    Mol Cancer Res; 2021 Mar; 19(3):465-474. PubMed ID: 33229401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.
    Jiang Y; Qiu Y; Minn AJ; Zhang NR
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5528-37. PubMed ID: 27573852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.
    Deshwar AG; Vembu S; Yung CK; Jang GH; Stein L; Morris Q
    Genome Biol; 2015 Feb; 16(1):35. PubMed ID: 25786235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data.
    Zaccaria S; Raphael BJ
    Nat Commun; 2020 Sep; 11(1):4301. PubMed ID: 32879317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.